Quantcast

Latest Generic drug Stories

2014-09-10 23:08:02

The Alabama Supreme Court ruled that brand-name drug companies can be sued for injuries caused by its generic equivalent if the brand-name manufacturer made misleading or inaccurate claims about the drug, and those claims were relied upon by the injured person’s physician; this decision confirms the court’s previous ruling last year. Port Washington, New York (PRWEB) September 10, 2014 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by...

2014-09-10 12:24:20

Ten-year savings hits record at nearly $1.5 trillion according to annual Generic Drug Savings in the U.S. report WASHINGTON, Sept. 10, 2014 /PRNewswire-USNewswire/ -- The Generic Pharmaceutical Association (GPhA) today released a report showing that generic drugs saved the United States health system $239 billion in 2013, a 14% increase over cost savings achieved in 2012, and the largest annual savings to date. The report also calculates that generic medications saved a record of nearly $1.5...

2014-09-08 12:29:59

Commission Alleges That AbbVie Inc. and Besins Healthcare Inc. Filed Sham Lawsuits; AbbVie and Teva Pharmaceuticals USA, Inc. Entered Anticompetitive Agreement to Delay Generic Entry WASHINGTON, Sept. 8, 2014 /PRNewswire-USNewswire/ -- In its latest action to ensure competition in the nation's healthcare markets, the Federal Trade Commission has filed a complaint in federal district court charging several major pharmaceutical companies with illegally blocking American consumers' access to...

2014-09-08 08:29:19

Mylan Free to Immediately Resume Distribution of Its Generic Precedex Product PITTSBURGH, Sept. 8, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today commented on a ruling by the U.S. District Court for the District of Maryland related to its product, Dexmedetomidine Hydrochloride Injection, 100 mcg (base)/mL, packaged in 200 mcg (base)/2 mL Single-dose Vials, which was approved by the U.S. Food and Drug Administration (FDA) as therapeutically equivalent to Hospira Inc.'s...

2014-09-01 12:23:29

LONDON, Sept. 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Markets for Generic Drugshttps://www.reportbuyer.com/product/2009161/Global-Markets-for-Generic-Drugs.html STUDY GOALS AND OBJECTIVESThe aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for prescription generic drugs. Important trends are identified and sales forecasts by product categories and major...

2014-08-29 12:24:42

PISCATAWAY, N.J., Aug. 29, 2014 /PRNewswire/ -- InnoPharma, Inc. today announced the approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for decitabine for injection, a generic version of Eisai Inc.'s DACOGEN®. InnoPharma developed the generic formulation of decitabine for injection and entered into an agreement with Sandoz, Inc., pursuant to which Sandoz will sell, market and distribute decitabine for injection in the United...

2014-08-28 23:10:26

The NAPSRX has received a small grant and awarded the 2014 Kennedy Educational Award in Washington, D.C. to support the future establishment and implementation of advanced Pharmaceutical Sales Vocational Education. Washington, DC (PRWEB) August 28, 2014 The NAPSRx announced today that it has received a small grant and awarded the 2014 Kennedy Educational Award in Washington, D.C. to support the future establishment and implementation of advanced Pharmaceutical Sales Vocational Educational...

2014-08-28 12:29:56

PITTSBURGH, Aug. 28, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its abbreviated new drug application (ANDA) for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the U.S. Food and Drug Administration (FDA). This product is the generic version of Teva's Copaxone® 40 mg/mL, which is indicated for the treatment of patients with relapsing forms of multiple sclerosis (MS)....

2014-08-27 12:30:26

Profit Attributable to Owners of the Company Up by 34.4% HONG KONG, Aug. 27, 2014 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the largest cardio-cerebral vascular ("CCV") drug franchise in China's prescription drug market, today announced the unaudited consolidated results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 June 2014...

2014-08-24 23:00:47

Over the five-year period, many thin film drug manufacturers will focus on developing a drug pipeline that encompasses more therapeutic classes, such as drugs that treat respiratory-related ailments. For these reasons, industry research firm IBISWorld has updated a report on the Thin Film Drug Manufacturing industry in its growing industry report collection. New York, NY (PRWEB) August 24, 2014 Over the past five years, the Thin Film Drug Manufacturing industry has exhibited rapid revenue...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.